Source: Annual Congress 2011 - Recent developments in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Sobradillo, R. Faner, N. Soler, E. Ballester, J. I. Aróstegui, J. Yagüe, J. Manel, A. Agusti (Barcelona, Spain). Activation of the inflammasome pathway during exacerbations of COPD. Eur Respir J 2011; 38: Suppl. 55, 420

Member's Comments

No comment yet.

Related content which might interest you: The inflammasome pathway in stable COPD and acute exacerbations Source: ERJ Open Res 2016: 00002-2016 Year: 2016 Caspase-1 pathway in COPD Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 Activation of IL-32 pathway in COPD Source: Annual Congress 2008 - Cell biology of asthma and COPD Year: 2008 The activation of NLRP3 inflammasome pathway in COPD is limited in local airways Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Andrographolide inhibits the activation of NLRP3 inflammasome in patients with COPD Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 Regulation of NF-kappaB-dependent cytokines during exacerbations of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 824s Year: 2006 Notch pathway signaling in asthma Source: Annual Congress 2006 - Markers of paediatric airway disease Year: 2006 Analysis of cytokine signaling pathway JAK-STAT through their activation in patients with asthma Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 Hedgehog pathway activation is altered in COPD patients Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Altered inflammasome activity in bacterial acute exacerbations of COPD (AECOPD) Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Activation of TGFβ/Smad signalling pathway in induced sputum of asthmatic children Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009 Extracellular nucleotides contribute to the pathogenesis of viral-induced exacerbations in COPD via P2X4/P2X7-receptor activation Source: International Congress 2019 – Mechanisms underlying respiratory infection Year: 2019 Elevated expression of the NLRP3 inflammasome in neutrophilic asthma Source: Eur Respir J 2014; 43: 1067-1076 Year: 2014 Statins worse pulmonary fibrosis through enhancing NLRP3 inflammasome activation Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 NLRP3 inflammasome is activated via phosphoinositide 3-kinase δ pathway in Aspergillus fumigatus-induced allergic airway inflammation Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 The role of complement activation in COPD exacerbation recovery Source: ERJ Open Res, 2 (4) 00027-2016; 10.1183/23120541.00027-2016 Year: 2016 The NLRP3 inflammasome in chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Clinical pathway for acute COPD exacerbations Source: Eur Respir J 2004; 24: Suppl. 48, 64s Year: 2004 JAK/STATs in asthma and COPD Source: Annual Congress 2004 - Transcription factors in airway disease Year: 2004